Azerbaijan is pushing forward on multiple fronts of non-oil economic diversification, and its pharmaceutical sector is increasingly emerging as a key pillar. Specifically, starting from next year, the government aims for a strong, radical, and long-awaited shift from oil and gas dependence. The inauguration of a major production facility by Scandens Pharmaceutical Industries Ltd. in the Absheron district signifies more than just a business expansion. It represents a strategic bet on the country’s future as a regional pharmaceutical hub.

On November 22, 2025, President Ilham Aliyev officially opened the Scandens plant in Hokmali, Absheron, accompanied by Economy Minister Mikayil Jabbarov and Scandens CEO Kamran Hasanov.

The facility, built to international standards with equipment from Germany, Switzerland, and Italy, is designed to manufacture approximately 800 million tablets and capsules per year across a wide range of therapeutic areas — including antibiotics, diabetology, hepatology, cardiology, allergology, gastroenterology, and more.

Backed by private investment worth 74 million manats, the project also benefited from government support: under an investment promotion document, Scandens received 6.5 million manats in concessions for........

© AzerNews